Cargando…
Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327263/ https://www.ncbi.nlm.nih.gov/pubmed/34350126 http://dx.doi.org/10.3389/fonc.2021.734761 |
Ejemplares similares
-
ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer
por: Wang, Junxiong, et al.
Publicado: (2021) -
Recruitment of the Adaptor Protein Grb2 to EGFR Tetramers
por: Kozer, Noga, et al.
Publicado: (2014) -
The Treatment of a Novel Epidermal Growth Factor Receptor (EGFR)-GRB2 Genetic Mutation Using Osimertinib in Metastatic Non-Small Cell Lung Cancer
por: Ramanathan, Siddharth, et al.
Publicado: (2023) -
Downregulation of ZNF280A inhibits proliferation and tumorigenicity of colorectal cancer cells by promoting the ubiquitination and degradation of RPS14
por: Tian, Binle, et al.
Publicado: (2022) -
Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer
por: Rey-Vargas, Laura, et al.
Publicado: (2022)